ANGI
Angi Inc.
ANGI trails on the overall score without a compensating advantage in the available component scores.
TMUS
T-Mobile US, Inc.
TMUS has the edge over ANGI overall, supported by stronger valuation and lower modeled downside.
ANGI Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| Under pressure | |
| Under pressure |
ANGI's revenue, profitability, cash flow and balance sheet are all currently under pressure.
TMUS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Strong | |
| Strong |
TMUS's profitability, cash flow and balance sheet are currently healthy, and its revenue is stable.
ANGI PE Valuation
ANGI has no meaningful PE right now: it lost money over the past year.
TMUS PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 13x | $171 | — |
| Current | 16x | $171 | — |
| Cheap | 21x | $218 | +27% |
| Fair | 26x | $274 | +60% |
| Expensive | 56x | $581 | +240% |
Historical ranges are pointers, not guarantees.
TMUS's PE is in its cheap range at 16x. If earnings grow as analysts expect, today's price would be 13x next year's earnings.
ANGI Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Strong growth | |
| Decline | |
| Improving | |
| Limited | |
| Low |
Analysts expect ANGI's earnings to grow and its profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
TMUS Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
TMUS has the edge over ANGI on the outlook, with more favorable revenue expectations.
ANGI Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.41 | — |
| Q3 2026 | -$5.71 | -965% |
| Q2 2026 | -$5.51 | -588% |
| Q1 2026 | $0.42 | -58% |
| Q4 2025 | $0.94 | +34% |
| Q3 2025 | $0.66 | -5.7% |
| Q2 2025 | $1.13 | +$1.23 |
| Q1 2025 | $1.00 | +$1.50 |
| Q4 2024 | $0.70 | +$1.50 |
ANGI has swung to a loss: it lost $5.71 per share over the past year, after a profit the year before.
TMUS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $13.49 | +30% |
| Q3 2026 | $10.37 | -0.2% |
| Q2 2026 | $9.56 | -9.7% |
| Q1 2026 | $9.41 | -8.1% |
| Q4 2025 | $9.72 | +0.6% |
| Q3 2025 | $10.39 | +18% |
| Q2 2025 | $10.59 | +33% |
| Q1 2025 | $10.24 | +39% |
| Q4 2024 | $9.66 | +39% |
TMUS has the edge over ANGI on earnings quality, reporting a profit while its opponent remains loss making.
ANGI Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $242M | -8.9% |
| Q2 2026 | $248M | -11% |
| Q1 2026 | $238.2M | -3.2% |
| Q4 2025 | $240.8M | -10% |
| Q3 2025 | $265.6M | -10% |
| Q2 2025 | $278.2M | -12% |
| Q1 2025 | $245.9M | -19% |
| Q4 2024 | $267.9M | +22% |
ANGI's revenue has slid since its 2022 peak: $242M last quarter, down 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.4% | -1.8 points |
| Q2 2026 | -94% | -101 points |
| Q1 2026 | -4% | -12 points |
| Q4 2025 | 2.5% | +1.7 points |
| Q3 2025 | 8.2% | +5.6 points |
| Q2 2025 | 6.3% | +3.4 points |
| Q1 2025 | 8.1% | +7.2 points |
| Q4 2024 | 0.8% | -4.1 points |
ANGI's operating margin was 6.4% last quarter, down 1.8 points from the same quarter a year ago.
TMUS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $23.6B | +7.4% |
| Q2 2026 | $22.8B | +7.9% |
| Q1 2026 | $23.1B | +11% |
| Q4 2025 | $24.3B | +11% |
| Q3 2025 | $22B | +8.9% |
| Q2 2025 | $21.1B | +6.9% |
| Q1 2025 | $20.9B | +6.6% |
| Q4 2024 | $21.9B | +6.8% |
TMUS has the edge over ANGI on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 24% | +3.4 points |
| Q2 2026 | 24% | -0.6 points |
| Q1 2026 | 19% | -3.5 points |
| Q4 2025 | 15% | -5.6 points |
| Q3 2025 | 21% | -3.2 points |
| Q2 2025 | 25% | +1.3 points |
| Q1 2025 | 23% | +2.6 points |
| Q4 2024 | 21% | +4 points |
TMUS has the edge over ANGI on profitability, with a higher operating margin.
ANGI Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $14.4M | +192% |
| Q2 2026 | $12.2M | -73% |
| Q1 2026 | -$33.6M | -$17.9M |
| Q4 2025 | $11.4M | -58% |
| Q3 2025 | $4.9M | -74% |
| Q2 2025 | $44.9M | -10% |
| Q1 2025 | -$15.7M | -265% |
| Q4 2024 | $27.1M | +$33.4M |
ANGI still generates free cash flow, though less than at its 2020 peak: $4M over the past year.
TMUS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $5.1B | +5.3% |
| Q2 2026 | $4.8B | +4.4% |
| Q1 2026 | $4.6B | +4.6% |
| Q4 2025 | $4.2B | +25% |
| Q3 2025 | $4.8B | +15% |
| Q2 2025 | $4.6B | +32% |
| Q1 2025 | $4.4B | +79% |
| Q4 2024 | $3.3B | +2% |
TMUS has the edge over ANGI on cash flow, with more consistent year-over-year improvement.
ANGI Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +1.6% | +659K shares |
| 1 year | -8.9% | -4M shares |
| 3 years | -19% | -9.5M shares |
| 5 years | -18% | -9.2M shares |
| Available history | -21% | -10.7M shares |
ANGI has the edge over TMUS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $46M |
| Q3 2025 | $26.3M |
| Q2 2025 | $66.6M |
| Q1 2025 | $9.8M |
| Q4 2024 | $2.9M |
ANGI spent $46M buying back its own shares over the past year, down 56% from the year before.
TMUS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -10.8M shares |
| 1 year | -4.9% | -55M shares |
| 3 years | -8.8% | -103M shares |
| 5 years | -15% | -182M shares |
| Available history | +24% | +207M shares |
TMUS has 1.1B diluted shares, down 4.9% from a year ago, with $12B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $2.4B |
| Q2 2026 | $2.3B |
| Q1 2026 | $4.8B |
| Q4 2025 | $2.4B |
| Q3 2025 | $2.5B |
| Q2 2025 | $2.6B |
| Q1 2025 | $2.5B |
| Q4 2024 | $4.7B |
TMUS spent $12B buying back its own shares over the past year, down 1.7% from the year before.
ANGI Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 1.8x | Healthy |
| Q3 2025 | 1.3x | Healthy |
| Q2 2025 | 1.2x | Healthy |
| Q1 2025 | 1.0x | Very low |
| Q4 2024 | 0.7x | Very low |
| Q3 2024 | 0.9x | Very low |
| Q2 2024 | 1.0x | Healthy |
ANGI's net debt is about 2.6 years of its operating earnings (EBITDA), up from a year a year ago.
TMUS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.0x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2026 | -0.0x | Net Cash |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 0.1x | Very low |
| Q2 2025 | -0.1x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | 2.4x | Moderate |
TMUS's net debt is less than a year of its operating earnings (EBITDA).
ANGI Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 49.8 | Neutral |
| Stochastic | 69.1 | Neutral |
ANGI's weekly RSI is 50 (neutral) and its Stochastic is 69 (neutral).
TMUS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 47.9 | Neutral |
| Stochastic | 42.1 | Neutral |
TMUS's weekly RSI is 48 (neutral) and its Stochastic is 42 (neutral).
ANGI PE vs Communication Services Sector
| Metric | ANGI | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 16x | — |
ANGI has no meaningful PE right now: it lost money over the past year.
TMUS PE vs Communication Services Sector
| Metric | TMUS | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 16x | Same PE |
| PE % | 1 | 26 | 25 pts below |
TMUS is trading at 16x earnings, in line with the Communication Services sector's median of 16x.
ANGI Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $6.26 | 1.1% above |
| 20 week MA | $5.71 | 11% above |
| 50 week MA | $7.58 | 16% below |
| 100 week MA | $11.6 | 45% below |
| 200 week MA | $18.0 | 65% below |
ANGI has the edge over TMUS on trend strength, trading above more of its moving averages.
TMUS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $159.1 | 7.5% above |
| 20 week MA | $172.0 | 0.5% below |
| 50 week MA | $187.8 | 8.9% below |
| 100 week MA | $212.9 | 20% below |
| 200 week MA | $188.7 | 9.4% below |
TMUS has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 9.4% below its 200-week average.
ANGI Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $83.6 | $132.7 | +59% |
| 2021 | $132.7 | $94.3 | -29% |
| 2022 | $94.3 | $22.3 | -76% |
| 2023 | $22.3 | $24.9 | +12% |
| 2024 | $24.9 | $16.5 | -34% |
| 2025 | $16.5 | $12.7 | -23% |
| 2026 YTD | $12.7 | $6.33 | -50% |
ANGI has finished lower in four of the last six years. It's down 50% so far in 2026.
TMUS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $77.2 | $132.9 | +72% |
| 2021 | $132.9 | $119.9 | -9.8% |
| 2022 | $119.9 | $140.0 | +17% |
| 2023 | $140.0 | $160.3 | +15% |
| 2024 | $160.3 | $223.0 | +39% |
| 2025 | $223.0 | $201.0 | -9.9% |
| 2026 YTD | $201.0 | $171.0 | -15% |
TMUS has the edge over ANGI on returns for 2026, with the stronger performance.